Corporate Misconduct Case Study: Biogenic Entities & Its Impact on Defrauded Investors

A lawsuit from the Securities and Exchange Commission (SEC) has exposed a multi-million dollar investment fraud scheme, revealing how a network of interconnected entities, collectively known as the “Biogenic Entities,” systematically defrauded over 55 investors out of nearly $7 million.

This elaborate deception, spanning from at least June 2017 to March 2021, centered on bogus investment contracts for a supposed “World-Class” and “Life Saving” medical device that promised substantial “passive income”.

The illicit gains from this scheme were funneled into lavish personal purchases, highlighting a fucked up example of corporate greed prioritizing personal enrichment over ethical business practices and investor well-being.

Inside the Allegations: Corporate Misconduct

The core of the Biogenic Entities’ misconduct involved selling investment contracts for a medical testing device, deceptively claiming it was manufactured by their own companies and would generate significant passive income. Investors were falsely assured they would receive $250 each time the device was used in a doctor’s office, with projected earnings of over $10,000 per month.

Contrary to these claims, the devices were never manufactured by the Biogenic Entities; instead, they were purchased from a third party at a mere fraction of the roughly $150,000 paid by each defrauded investor.

The fraud ran deeper than false manufacturing claims. Defendants lied about having over 1,400 devices earning money for existing investors, when in reality, fewer than 70 devices were ever acquired. Doctors seldom used these devices, often storing them or returning them to the defendants.

To maintain the illusion, phony usage reports and billing invoices were fabricated by Julie Youssef or Zach Cargnino, providing investors with a misleading impression of active device use and impending returns.

No investors ever received money from the actual use of a device; instead, their purported “passive income” derived from Ponzi payments.

Zach Cargnino or Susann Cargnino facilitated these payments using funds from new investors, meaning early investors were paid with money from later victims. In at least one instance, an investor received “usage” revenue payments from money they had themselves paid to purchase additional investment contracts.

Inside the Allegations: Corporate Misconduct

The heart of the fraud lay in the misrepresentation of a diagnostic medical device. Investors were led to believe they were purchasing an interest in a “patented, Life Saving Medical Device” manufactured by the Biogenic Entities, which would generate significant returns.

These companies, however, did not manufacture any devices; instead, they acquired them from a third party at a fraction of the $150,000 price point charged to investors. This core deception formed the foundation of their illicit operations, enriching the defendants while deceiving investors.

To further the scheme, the defendants propagated numerous falsehoods, including claims of having more than 1,400 devices operating nationwide and generating over $10,000 per month in passive income for existing investors.

In reality, fewer than 70 devices were ever purchased, and doctors rarely used them, often storing or returning them. The illusion of profitability was maintained through fabricated usage reports and billing invoices, which gave investors a false sense of security and impending returns. These fraudulent documents were critical in sustaining the deception, as actual device use generated no income for investors.

The promised “passive income” for investors was not derived from device usage, but from a classic Ponzi scheme. Payments to earlier investors were made using funds collected from new investors, a deceptive cycle that concealed the lack of legitimate revenue generation. In some instances, investors unknowingly received payments that were simply portions of their own previously invested capital, further demonstrating the circular nature of the fraud.

Corporate Timeline of Deception

The defendants established and operated various entities to facilitate their fraudulent activities, often changing names to evade scrutiny. This timeline outlines the progression of the corporate structures involved:

Date	Entity/Action	Key Information
August 2016	Diagnostic Link LTD LLC incorporated	Susann Cargnino as member/owner, Zach Cargnino as CFO. Predecessor to Vital Systems. Received ~$176,000 from 4 investors.
August 2016	Capital Care Management LLC created	Susann Cargnino as sole member/owner; principal office at 8000 Yankee Rd., Ottawa Lake, Michigan. Later registered in Michigan with Zach Cargnino as authorized agent/CFO.
June 2017	Fraudulent scheme begins	Defendants start defrauding investors.
November 2017	Vital Systems LTD LLC incorporated	Susann Cargnino as sole member/owner, Zach Cargnino as primary officer. Received ~$1.5 million from 7 investors.
February 2018	Biogenic Inc. incorporated	Susann Cargnino as sole member/owner, Zach Cargnino as primary officer. Received ~$5.4 million from 36 investors.
June 2018	Property purchase (9182 Cherry Point Road)	Susann Cargnino used $675,000 of investor proceeds; later re-titled to Zach Cargnino.
August 2018	Property purchase (9194 Cherry Point Road)	Susann Cargnino used $325,000 of investor proceeds; later sold.
October 2018	Biotek Holdings LLC incorporated	Susann Cargnino (“Ashley Walker” pseudonym) as registered agent/officer. Received ~$759,000 (with Tek Wellness) from 7 investors.
March 2019	Tek Wellness, Inc. incorporated	Susann Cargnino (“Ashley Walker” pseudonym) as registered agent/officer. Received ~$759,000 (with Biotek) from 7 investors.
March 2019	Property purchase (8962 Cherry Point Road)	Susann Cargnino used $800,000 of investor proceeds.
March 2021	Fraudulent scheme ends (at least)	Period of alleged fraud concludes.
March 26, 2021	Property listed for sale (9194 Cherry Point Road)	After SEC subpoenas were served, the property was listed.
May 26, 2021	Property sold (9194 Cherry Point Road)	The property was sold for $500,000.
September 23, 2021	SEC Complaint filed	The Securities and Exchange Commission formally files its complaint against the defendants.

Regulatory Capture & Loopholes

The complaint alleges that no registration statement was ever filed with the Commission for these investment contract offerings, nor did any exemption from registration apply. This lack of registration directly violated securities laws designed to protect investors by ensuring transparency and proper disclosure.

The failure to register these securities allowed the defendants to operate outside the standard regulatory oversight, creating a fertile ground for their deceptive practices.

The use of pseudonyms by key defendants, such as Susann Cargnino using “Susann Ashley Walker” or “Ashley Walker” and Zachari Alan Cargnino using “Zach Alan,” further illustrates an attempt to exploit loopholes and obscure their identities.

These aliases were employed on company filings, email accounts, and public documents, particularly after public allegations of misconduct emerged. This strategic obfuscation allowed them to continue their scheme by making it difficult for investors and potentially regulators to connect new ventures with past fraudulent activities or individuals with prior legal issues.

Profit-Maximization at All Costs

The business model was predicated on extracting maximum profit from unsuspecting investors, demonstrating a clear prioritization of revenue over ethical conduct. They purchased medical devices from a third party at a fraction of the price, only to sell them to investors at a significant markup, claiming to be the manufacturer.

This inflated pricing, alongside the promise of high passive income, served to lure investors into what was, in essence, a sophisticated resale operation disguised as a cutting-edge medical device business.

The illusion of comprehensive support and “totally passive” income was a key selling point, with defendants offering “accounting services and support” for a monthly fee. Despite these promises, no separate checking accounts were established for collecting revenues, and investors were never billed for the service fee.

The services themselves were entirely illusory, with fake usage reports and invoices being the only “support” provided. This highlights a calculated strategy to maximize investor contributions while minimizing legitimate operational costs, embodying a profit-at-all-costs mentality that disregarded investor welfare.

The Economic Fallout

The financial devastation wrought by the Biogenic Entities’ scheme is significant, with over 55 investors collectively losing approximately $6.8 million. This substantial sum represents the hard-earned capital of individuals who were promised a secure, passive income stream, only to find their investments funding the lavish lifestyles of the perpetrators.

The impact extends beyond mere financial loss, as many investors likely relied on these promised returns for their financial security or retirement.

The Ponzi payments further compounded the economic damage, as funds from new investors were used to pay off earlier ones, creating a facade of legitimacy that ultimately collapsed. This predatory model ensured that while some investors received initial payouts, the vast majority were left with nothing, their capital absorbed into the fraudulent enterprise.

The scheme’s termination left a trail of unfulfilled promises and significant economic hardship for those who were defrauded.

Community Impact: Local Lives Undermined

The impact of the scheme extended directly into the lives of the defendants’ local community, specifically Manitou Beach, Lenawee County, Michigan, where Susann Cargnino and Zach Cargnino resided. Millions of dollars in defrauded investor money were used to acquire three residential properties in Manitou Beach.

These properties, purchased with illicit proceeds, represent tangible assets acquired through the direct financial harm of dozens of individuals.

The ostensible offices of the Biogenic Entities were also purportedly maintained within this judicial district, further intertwining the fraudulent activities with the local area. The purchase of residential properties, jet skis, jewelry, vacation rentals, and home improvements with investor funds directly demonstrated the localized benefit derived from a nationwide fraud.

This case highlights how fraudulent schemes can directly impact the real estate market and economic landscape of specific communities through illicit wealth accumulation.

The PR Machine: Corporate Spin Tactics

The defendants employed sophisticated tactics to manage their public image and evade detection, operating a veritable “PR machine” to spin their narrative and deflect scrutiny. When public allegations of misconduct or fraud surfaced, including lawsuits and condemnations on websites like Ripoff Report, Zach Cargnino and his team took swift action.

They would change the name of the operative Biogenic entity and all associated email addresses to obscure connections and maintain an appearance of legitimacy.

Furthermore, key individuals adopted pseudonyms to disguise their involvement, such as Gary Youssef becoming “Gary Joseph,” Julie Youssef changing to “Julie Joseph” or “Julie Ann,” and Zach Cargnino using “Zach Alan”.

Susann Cargnino also utilized her middle and maiden names, “Susan Walker” or “Ashley Walker,” on company filings and other public documents.

These deliberate efforts to obfuscate identities and corporate structures served as a deceptive shield against public scrutiny and regulatory oversight.

Wealth Disparity & Corporate Greed

The Biogenic Entities case vividly illustrates the extreme consequences of unchecked corporate greed and its contribution to wealth disparity. While over 55 investors suffered nearly $7 million in losses, Susann and Zach Cargnino, the primary beneficiaries of the fraud, reaped hundreds of thousands, if not millions, of dollars in illicit proceeds. Their expenditures included multiple residential properties, luxury items like jet skis and jewelry, vacation rentals, expensive home improvements, and even the extinguishment of nearly $100,000 in pre-existing bankruptcy debt.

This stark contrast between the significant losses incurred by investors and the lavish personal gains of the defendants underscores a fundamental imbalance within the economic system. The case highlights how profit-seeking at its most extreme can lead to blatant disregard for ethical boundaries and the financial well-being of others, funneling collective investment into private extravagance.

Global Parallels: A Pattern of Predation

While this case focuses on a specific investment fraud in the medical device sector, its underlying mechanisms—deceptive advertising, Ponzi schemes, and the exploitation of regulatory gaps—are hallmarks of broader patterns of corporate predation seen globally.

Similar schemes emerge across various sectors, often preying on the desire for passive income or high returns, whether in real estate, cryptocurrency, or other nascent industries. The consistent thread is a systemic incentive structure that can reward rapid, illicit wealth accumulation over sustainable, ethical growth.

These patterns often involve complex corporate structures and the strategic use of shell entities to obscure true ownership and financial flows.

This diffusion of responsibility and obfuscation of funds are common tactics employed by bad actors in different jurisdictions, demonstrating a global playbook for financial fraud. The ease with which such schemes can proliferate across state and national borders points to a pervasive vulnerability within regulatory frameworks designed to protect consumers and investors.

Corporate Accountability Fails the Public

The legal action against the Biogenic Entities, while aiming to hold them accountable, also exposes limitations in how corporate misconduct is addressed.

The legal complaint seeked permanent injunctions, disgorgement of ill-gotten gains, and civil monetary penalties. However, the process of recovery for defrauded investors can be lengthy and complex, with full restitution often elusive.

This case highlights how accountability can be challenging when individuals and entities actively work to conceal their identities and financial activities. The repeated changes in company names and the use of pseudonyms underscore a calculated effort to evade detection, which can complicate enforcement efforts. While the SEC is seeking significant relief, the very existence of such a widespread and prolonged fraud demonstrates a gap in proactive corporate oversight that allowed the scheme to flourish for years.

Legal Minimalism: Doing Just Enough to Stay Plausibly Legal

The defendants’ alleged actions, such as failing to register their investment contracts, demonstrate a calculated approach to operating on the fringes of legality. By offering “investment contracts” for medical devices without proper registration, they attempted to create a veneer of legitimate business while bypassing crucial investor protections mandated by securities law. This behavior exemplifies a legal minimalism, where the form of compliance is skirted, and the intent of the law—to protect the public—is entirely disregarded.

This strategy is often seen in corporate structures where regulatory compliance is treated as a hurdle to be navigated rather than a foundational principle of ethical operations. The continuous incorporation of new entities and the use of aliases suggest a deliberate attempt to stay one step ahead of scrutiny, treating regulatory frameworks as a game of cat and mouse rather than a system for ensuring fair play. Such actions reward those who prioritize profit above all else, even if it means operating in a legally ambiguous or outright illicit manner.

Profiting from Complexity: When Obscurity Shields Misconduct

The Biogenic Entities case showcases how complex corporate structures and financial layering can be weaponized to shield misconduct and obscure the flow of illicit funds. The fraud involved multiple limited liability companies and corporations—Biogenic, Diagnostic Link, Vital Systems, BioTek Holdings, Tek Wellness, and Capital Care Management—all seemingly connected to Susann and Zach Cargnino. This intricate web of entities, with funds layered between their bank accounts, served to complicate financial tracking and divert attention from the ultimate beneficiaries.

The use of pseudonyms and the frequent changing of company names further added to this complexity, making it challenging for investigators and defrauded investors to trace the true actors and follow the money. Such deliberate obfuscation is a hallmark of late-stage capitalist systems where diffusion of responsibility and opacity can be a strategic tool.

It allows individuals to operate behind multiple corporate veils, complicating legal and financial accountability and enabling prolonged fraudulent activities.

This Is the System Working as Intended

The Biogenic Entities fraud is not an isolated incident but rather a predictable outcome when profit is structurally prioritized over people within a neoliberal economic framework. The case illustrates how an environment of deregulation and profit-maximization incentives can create fertile ground for deceptive practices, even when explicit laws are violated.

The ability of defendants to operate for years, defrauding dozens of investors and accumulating millions in illicit wealth, suggests that existing safeguards were either insufficient or circumvented with ease.

The case underscores that the system, in certain respects, functions as intended by allowing capital accumulation, even through illicit means, to persist until regulatory bodies intervene. The pursuit of “passive income” and “world-class” investment opportunities, while appealing to investors, can become a vulnerability in a system that sometimes struggles to distinguish legitimate innovation from predatory schemes.

This incident serves as a powerful reminder that robust regulation and vigilant oversight are essential counterbalances to the inherent pressures of unchecked profit-seeking.

Conclusion

The Biogenic Entities investment fraud represents a deeply concerning chapter in corporate misconduct, costing over 55 investors nearly $7 million through a web of deceit and false promises. The case highlights how a focus on profit maximization, coupled with a willingness to exploit regulatory gaps and engage in blatant misrepresentation, can lead to widespread financial harm. The use of Ponzi payments, fabricated reports, and elaborate corporate structures underscores the sophisticated nature of the fraud.

The lavish personal expenditures by the key perpetrators, directly funded by the losses of their victims, are a stark reminder of the human cost of such schemes. While legal action seeks to rectify the wrongdoing, the lasting impact on defrauded individuals and the broader public trust remains. This situation calls for continued scrutiny of investment opportunities that promise overly generous passive returns and a renewed commitment to robust regulatory frameworks to protect vulnerable investors.

Frivolous or Serious Lawsuit?

This lawsuit is undeniably serious, stemming from detailed allegations of widespread financial fraud.

The complaint meticulously outlines how defendants solicited millions from investors based on false claims about medical devices, their manufacturing, and the income they would generate. The assertion that payments to investors were actually Ponzi scheme distributions, rather than legitimate earnings, indicates a fundamental and intentional deception.

The legal filing details the specific roles of individuals and entities, their use of pseudonyms to evade detection, and the substantial sums of money diverted for personal enrichment.

These documented facts, including the failure to register securities and the fabrication of financial reports, provide a strong foundation for the legal claims of securities fraud and unregistered offerings. The case represents a significant grievance against corporate entities that allegedly prioritized illicit gains over investor protection and ethical conduct.

There is a press release on the SEC’s website about this pyramid scheme: https://www.sec.gov/enforcement-litigation/litigation-releases/lr-26294

💡 Explore Corporate Misconduct by Category

Corporations harm people every day — from wage theft to pollution. Learn more by exploring key areas of injustice.

• 💀 Product Safety Violations — When companies risk lives for profit.
• 🌿 Environmental Violations — Pollution, ecological collapse, and unchecked greed.
• 💼 Labor Exploitation — Wage theft, worker abuse, and unsafe conditions.
• 🛡️ Data Breaches & Privacy Abuses — Misuse and mishandling of personal information.
• 💵 Financial Fraud & Corruption — Lies, scams, and executive impunity.

NOTE:

This website is facing massive amounts of headwind trying to procure the lawsuits relating to corporate misconduct. We are being pimp-slapped by a quadruple whammy:

1. The Trump regime's reversal of the laws & regulations meant to protect us is making it so victims are no longer filing lawsuits for shit which was previously illegal.
2. Donald Trump's defunding of regulatory agencies led to the frequency of enforcement actions severely decreasing. What's more, the quality of the enforcement actions has also plummeted.
3. The GOP's insistence on cutting the healthcare funding for millions of Americans in order to give their billionaire donors additional tax cuts has recently shut the government down. This government shut down has also impacted the aforementioned defunded agencies capabilities to crack down on evil-doers. Donald Trump has since threatened to make these agency shutdowns permanent on account of them being "democrat agencies".
4. My access to the LexisNexis legal research platform got revoked. This isn't related to Trump or anything, but it still hurt as I'm being forced to scrounge around public sources to find legal documents now. Sadge.

All four of these factors are severely limiting my ability to access stories of corporate misconduct.

Due to this, I have temporarily decreased the amount of articles published everyday from 5 down to 3, and I will also be publishing articles from previous years as I was fortunate enough to download a butt load of EPA documents back in 2022 and 2023 to make YouTube videos with.... This also means that you'll be seeing many more environmental violation stories going forward :3

Thank you for your attention to this matter,

Aleeia (owner and publisher of www.evilcorporations.com)

Also, can we talk about how ICE has a $170 billion annual budget, while the EPA-- which protects the air we breathe and water we drink-- barely clocks $4 billion? Just something to think about....